Trumenba 60 ug/.5mL

Trumenba 60 ug/0.5mL is a meningococcal group B vaccine designed to help prevent infections caused by Neisseria meningitidis serogroup B. This intramuscular injection is suitable for individuals at risk of meningococcal disease.

Trumenba is used to protect against meningococcal group B bacteria, which can cause severe infections like meningitis and sepsis. This vaccine is typically administered to individuals who are at increased risk of exposure to the bacteria. It is important to consult with a healthcare provider to determine if Trumenba is appropriate for your specific situation.

Common effects of Trumenba may include pain, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or muscle aches following vaccination. These effects are usually temporary and resolve on their own.

Trumenba should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine.

Trumenba may interact with certain medications or other vaccines. It is advisable to discuss your current medications and vaccination schedule with a healthcare provider to avoid potential interactions. Alcohol and other substances should be considered in consultation with a healthcare professional.